Analysis of p53 Tumor Suppressor Gene in Families with Multiple Glioma Patients
暂无分享,去创建一个
J. Isola | M. Matikainen | K. Syrjäkoski | R. Sankila | H. Haapasalo | M. Niemelä | P. Helén | K. Simola | N. Paunu | K. Syrjäkoski
[1] J. Isola,et al. High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas , 2000, Neuropathology and applied neurobiology.
[2] K. Hemminki,et al. Cancers in the first-degree relatives of children with brain tumours , 2000, British Journal of Cancer.
[3] R. Jenkins,et al. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. , 2000, American journal of medical genetics.
[4] M. Roncalli,et al. An Ava I polymorphism in the TP53 gene. , 1999, Molecular and cellular probes.
[5] H. Grönberg,et al. Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study , 1999, International journal of cancer.
[6] P. Kleihues,et al. Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations , 1998, Journal of neuropathology and experimental neurology.
[7] D. Evans,et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. , 1997, Cancer research.
[8] R Miike,et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.
[9] J. Bruner,et al. Correlation of p53 immunoreactivity and sequencing in patients with glioma , 1996, Molecular carcinogenesis.
[10] G. Thomas,et al. Incidence of germ‐line p53 mutations in patients with gliomas , 1995, International journal of cancer.
[11] D. Louis,et al. Hereditary Tumor Syndromes of the Nervous System: Overview and Rare Syndromes , 1995, Brain pathology.
[12] P. Kleihues,et al. Familial Brain Tumour Syndrome Associated with a p53 Germline Deletion of Codon 236 , 1995, Brain pathology.
[13] T. Visakorpi,et al. Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.
[14] H. Saya,et al. Germline p53 gene mutations in subsets of glioma patients. , 1994, Journal of the National Cancer Institute.
[15] A. Craft,et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.
[16] J. Cairncross,et al. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma , 1994, Annals of neurology.
[17] W. Cavenee,et al. Gliomas in Families , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[18] H. Saya,et al. Codon 72 polymorphism of the TP53 gene. , 1990, Nucleic acids research.
[19] J. Flannery,et al. Cancer in relatives of children with central-nervous-system neoplasms. , 1984, The New England journal of medicine.
[20] L. Schuman,et al. Epidemiology of primary central nervous system neoplasms. II. Case-control study. , 1970, American journal of epidemiology.
[21] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[22] D. Louis,et al. Glioblastoma multiforme in four siblings: A cytogenetic and molecular genetic study , 2005, Journal of Neuro-Oncology.
[23] P. Kleihues,et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.
[24] K. Tamura,et al. Germline p53 mutation at codon 133 in a cancer-prone family , 1997, Journal of Molecular Medicine.